MedTrace Logo

Extracorporeal Shock Wave Therapy for Dysmenorrhea

NCT04662814 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-03-24

No results posted yet for this study

Summary

purpose of this study to investigate the effect of Extracorporeal shock wave therapy on pain and prostaglandin level in patient with primary dysmenorrhea

Conditions

  • Primary Dysmenorrhea

Interventions

OTHER

shock wave therapy

Intervention group is by shock wave therapy. A radial shock wave device (EME, ITALY) was used. for 4 sessions (one session before the expected day of period and session per day for day1 , day 2 and day 3 of each menstrual cycle) for three successive periods.

OTHER

dietary modification

Participants will receive dietary modification for three consecutive months dietary modification will be low caffeine and high water and liquids intake and reduce the uptake of fast food, should be followed for 3 months

Sponsors & Collaborators

  • Ghada ebrahim El Refaye -Faculty of Physical Therapy, Cairo University, Egypt

    collaborator UNKNOWN

  • Sohier Mahmmoud El Koseiry- Faculty of Physical Therapy, Cairo University, Egypt

    collaborator UNKNOWN

  • MTI University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-12
Primary Completion
2020-12-24
Completion
2021-01-27

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04662814 on ClinicalTrials.gov